Patent 4666903 Issued on May 19, 1987. Estimated Expiration Date: August 13, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Benzodiazepine antagonists are used to regenerate the sensitivity response to and prevent tolerance of benzodiazepine which otherwise develops during chronic benzodiazepine exposure. The administration of a plurality of time spaced doses of the antagonist also prevents benzodiazepine withdrawal symptoms. The preferred benzodiazepine antagonist is flumazepil.
Sandra E. File, "Recovery from Lorazepam Tolerance and the Effects of a Benzodiazepine Antagonist (RO 15-1788) on the Development of Tolerance," Psychopharmacology (1982) 77:284-288
Scott E. Lukas, Roland R. Griffiths, "Precipitated Withdrawal by a Benzodiazepine Receptor Antagonist (RO 15-1788) After 7 Days of Diazepam", Science, vol. 217, 17 Sep. 1982
L. F. McNicholas and W. R. Martin, "The Effect of a Benzodiazepine Antagonist, RO15-1788, In Diazepam Dependent Rats," Life Sciences, vol. 31, pp. 731-737
R. J. Lamb and R. R. Griffiths, "Effects of Repeated Ro 15-1788 Administration in Benzodiazepine-Dependent Baboons", European Journal of Pharmacology, vol. 110, No. 2, pp. 257-261